NDC 64720-321

Metaxalone

Metaxalone

Metaxalone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Corepharma, Llc. The primary component is Metaxalone.

Product ID64720-321_ae0896e9-ce19-4eda-8cda-3ceab9d674e4
NDC64720-321
Product TypeHuman Prescription Drug
Proprietary NameMetaxalone
Generic NameMetaxalone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2007-11-01
Marketing End Date2020-04-01
Marketing CategoryNDA / NDA
Application NumberNDA013217
Labeler NameCorePharma, LLC
Substance NameMETAXALONE
Active Ingredient Strength800 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE]
NDC Exclude FlagN

Packaging

NDC 64720-321-10

100 TABLET in 1 BOTTLE (64720-321-10)
Marketing Start Date2007-11-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64720-321-10 [64720032110]

Metaxalone TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-11-01
Marketing End Date2020-04-01

NDC 64720-321-01 [64720032101]

Metaxalone TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-11-01
Marketing End Date2011-01-14

NDC 64720-321-50 [64720032150]

Metaxalone TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-11-01
Marketing End Date2020-04-01

Drug Details

Active Ingredients

IngredientStrength
METAXALONE800 mg/1

OpenFDA Data

SPL SET ID:da237968-1c52-47c3-986b-4f878bd6b173
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 351254
  • UPC Code
  • 0364720321105
  • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]

    Medicade Reported Pricing

    64720032110 METAXALONE 800 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Metaxalone" or generic name "Metaxalone"

    NDCBrand NameGeneric Name
    0115-1745MetaxaloneMetaxalone
    0115-1748MetaxaloneMetaxalone
    0185-0448MetaxaloneMetaxalone
    0276-0508MetaxaloneMetaxalone
    0527-1435MetaxaloneMetaxalone
    0591-2341MetaxaloneMetaxalone
    0904-6831MetaxaloneMetaxalone
    10544-002MetaxaloneMetaxalone
    10544-144MetaxaloneMetaxalone
    21695-585MetaxaloneMetaxalone
    33261-724MetaxaloneMetaxalone
    35356-570MetaxaloneMetaxalone
    42254-040MetaxaloneMetaxalone
    42291-587MetaxaloneMetaxalone
    43063-239MetaxaloneMetaxalone
    43063-581MetaxaloneMetaxalone
    45865-942MetaxaloneMetaxalone
    45865-985MetaxaloneMetaxalone
    50090-1182MetaxaloneMetaxalone
    50090-3174MetaxaloneMetaxalone
    50090-3297MetaxaloneMetaxalone
    50090-3650MetaxaloneMetaxalone
    50090-3670MetaxaloneMetaxalone
    68001-004MetaxaloneMetaxalone
    68084-135MetaxaloneMetaxalone
    68151-4668MetaxaloneMetaxalone
    68258-7100MetaxaloneMetaxalone
    68387-108MetaxaloneMetaxalone
    68788-7073MetaxaloneMetaxalone
    68788-7018MetaxaloneMetaxalone
    68788-6466MetaxaloneMetaxalone
    68788-9896MetaxaloneMetaxalone
    68788-9277MetaxaloneMetaxalone
    70332-330MetaxaloneMetaxalone
    70518-0818MetaxaloneMetaxalone
    70518-0771MetaxaloneMetaxalone
    70518-1161MetaxaloneMetaxalone
    70934-160MetaxaloneMetaxalone
    71335-0099MetaxaloneMetaxalone
    71335-0186MetaxaloneMetaxalone
    71205-016MetaxaloneMetaxalone
    71335-0375MetaxaloneMetaxalone
    71335-0958MetaxaloneMetaxalone
    50228-323MetaxaloneMetaxalone
    50436-0448MetaxaloneMetaxalone
    50268-530MetaxaloneMetaxalone
    50436-3024MetaxaloneMetaxalone
    51655-162MetaxaloneMetaxalone
    51655-167MetaxaloneMetaxalone
    51655-163MetaxaloneMetaxalone

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.